Clinical Follow-Up of Responses to Treatment with Benznidazol in Amazon: A Cohort Study of Acute Chagas Disease by Ana Yecê das Neves Pinto (415537)

“…Added, there was evidence of therapeutic failure immediately following treatment, as demonstrated by xenodiagnosis and blood culture methods in 2.3% and 3.5% of cases, respectively. There was a strong evidence of antibody clearing in the fourth year after treatment and continuous decrease of antibody titers. …”

Chronic treatment of non-small-cell lung cancer cells with gefitinib leads to an epigenetic loss of epithelial properties associated with reductions in microRNA-155 and -200c by Michiko Narita (124347)

“…Interestingly, the inhibition of both miR-155 and miR-200c in HCC827 cells without gefitinib induced significant increases in smad2 and zeb1 along with a dramatic decrease in E-cadherin and a slight increase in vimentin. …”

Loss of Slfn3 induces a gender-dependent repair vulnerability after 50% bowel resection by Emilie DeKrey (9389738)

“…<p></p><p>Bowel resection accelerates enterocyte proliferation in the remaining gut that may have suboptimal absorptive and digestive capacity because of proliferation-associated decrease in functional differentiation markers. <a>We hypothesized that although Schlafen 3 (Slfn3) is an important regulator of murine enterocytic differentiation, Slfn3 would have less impact on the bowel resection adaptation where accelerated proliferation takes priority over differentiation. …”

A Bayesian Nonlinear Mixed-Effects Regression Model for the Characterization of Early Bactericidal Activity of Tuberculosis Drugs by Divan Aristo Burger (645493)

Supplementary Material for: Incidence of Uncommon Clinical Events in USA Patients with Dialysis-Dependent and Nondialysis-Dependent Chronic Kidney Disease: Analysis of Electronic H... by Sultan A.A. (10915740)

Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis by Eric R. Strieter (1319670)

Table4_LeishIF3d is a non-canonical cap-binding protein in Leishmania.XLSX by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Image8_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Image1_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis by Eric R. Strieter (1319670)

Table1_LeishIF3d is a non-canonical cap-binding protein in Leishmania.XLSX by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Table2_LeishIF3d is a non-canonical cap-binding protein in Leishmania.XLSX by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Table3_LeishIF3d is a non-canonical cap-binding protein in Leishmania.XLSX by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Image7_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis by Eric R. Strieter (1319670)

Image2_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Restricting the ψ Torsion Angle Has Stereoelectronic Consequences on a Scissile Bond: An Electronic Structure Analysis by Eric R. Strieter (1319670)

Image6_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Image3_LeishIF3d is a non-canonical cap-binding protein in Leishmania.TIF by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”

Presentation1_LeishIF3d is a non-canonical cap-binding protein in Leishmania.PPTX by Priyanka Bose (7110071)

“…<p>Translation of most cellular mRNAs in eukaryotes proceeds through a cap-dependent pathway, whereby the cap-binding complex, eIF4F, anchors the pre-initiation complex at the 5′ end of mRNAs driving translation initiation. …”